Examination of transforming growth factor β1 expression in the serum and tumor tissue of gastric cancer

International Surgery

Volumn 94, Issue 2, 2009, Pages 182-188

  Suda, Atsuko ^a   Saito, Noboru ^a   Seshimo, Akiyoshi ^a   Kameoka, Shingo ^a   Kobayashi, Makio ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Gastric cancer; Immunohistochemical expression; Tgf 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; BLOOD; CANCER INVASION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; STOMACH TUMOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 75449101406     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Massague J. The transforming factor-beta family. Annu Rev Cell Biol 1990; 6: 597-641
2. Mitsuyasu K. Transcriptional regulation by the transforming growth factor-beta signaling [in Japanese]. Tanpakusitsu Kakusan Kouso 2003; 48(16): 2227-2233
3. Mizoi T, Ohtani H, Miyazono K, Miyazawa M, Matsuno S, Nagura H. Immunoelectron microscopic localization of transforming growth factor beta-1 and latent transforming growth factor beta-1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells. Cancer Res 1993; 53(1): 183-190 (Pubitemid 23019396)
4. Miyazono K, Suzuki H, Imamura T. Regulation of TGF-beta signaling and its roles in progression on tumors. Cancer Sci 2003; 94(3): 203-234 (Pubitemid 36575887)
5. Azuma H, Ehata S, Miyazaki H, Watabe T, Maruyama O, Imamura T et al. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. J Natl Cancer Inst 2005; 97(23): 1734-1746
6. Heldin C-H, Miyazono K, ten Dijke P. TGF-beta signaling from cell membrane to nucleus through Smad proteins. Nature 1997; 390(6659): 465-471
7. Daiko W, Saito N, Kameoka S. Clinical significance of TGFbeta1 expression in evaluation of the malignancy of colorectal cancer [in Japanese with English abstract]. J Jpn Soc Coloproctol 2005; 58: 377-382
8. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 2nd English edition. Gastric Cancer 1998; 1: 10-24
9. Tomita N, Ohnishi T, Tada M, et al. A novel gene marker for colon cancer. J Colorectal Cancer 1998; 51(10): 1125-1131 (Pubitemid 28513963)
10. Konrad L, Scheiber JA, Volck-Badouin E, Keilani MM, Laible L, Brandt H et al. Alternative splicing of TGF-betas and their high-affinity receptors TβRI, TβRII and TβRIII (betaglycan) reveal new variants in human prostatic cells. BMC Genomics 2007; 8: 318
11. Ohgushi M, Kuroki S, Fukamachi H, O'Reilly LA, Kuida K, Strasser A et al. Transforming growth factor β-dependent sequential activation of Smad, Bim, and Caspase-9 mediates physiological apotosis in gastric epithelial cells. Mol Cell Biol 2005; 25(22): 10017-10028
12. Dumont N, Arteaga CL. Transforming growth factor-β and breast cancer: tumor promoting effects of transforming growth factor-β. Breast Cancer Res 2000; 2(2): 125-132 (Pubitemid 32223575)
13. Eagle SJ, Hoying JB, Boivin GP, Ormsby I, Gartside PS, Doetschman T. Transforming growth factor betal suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. Cancer Res 1999; 59(14): 3379-3386 (Pubitemid 29334496)
14. Ellenreider V, Buck A, Gress TM. TGFbeta-regulated transcriptional mechanisms in cancer. International Journal of Gastrointestinal Cancer. 2002; 31(1-3): 61-70
15. Kim SG, Jong HS, Kim TY, Lee JW, Kim NK, Hong SH et al. Transforming growth factor-β1 induces apotosis through Fas ligand-independent activation of the Fas death pathway in human gastric SNU-620 carcinoma cells. Mol Biol Cell 2004; 15(2): 420-434
16. Han G, Lu SL, Li AG, He W, Corless CL, Kulesz-Martin M et al. Distinct mechanisms of TGF-β1-mediated epithelial-tomesenchymal transition and metastasis during skin carcinogenesis. J Clin Invest 2005; 115(7): 1714-1723 (Pubitemid 40979710)
17. Culhaci N, Sagol O, Karademir S, Astarcioglu H, Astarcioglu H, Soyturk M et al. Expression of transforming growth factorbeta-1 and p27 in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristics. BMC Cancer 2005; 5: 98
18. Ohta S, Yanagihara K, Nagata K. Mechanism of apoptotic cell death of human gastric carcinoma cells mediated by transforming growth factor beta. Biochem J 1997; 325: (Pt-3)777-782 (Pubitemid 27285534)
19. Xin-Zi C, Jeung-Ook Y, Kwang-Youl L, Ito K, Sasakura C, Qing-Lin L et al. RUNX3 suppresses gastric epithelial cell growth by inducing P21 expression in cooperation with transforming growth factor β-activated SMAD. Mol Cell Biol 2005; 25(18): 8097-8107
20. Sue SR, Chari RS, Kong FM, Mills JJ, Fine RL, Jirtle RL et al. Transforming growth factor-beta receptors and mannose 6-phosphate/insukin-like growth factor-II receptor expression in human hepatocellular carcinoma. Ann Surg 1995; 222(2): 171-178
21. MacKay SL, Yaswen LR, Tarnuzzer RW, Moldawer LL, Bland KI, Copeland EM et al. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGFbeta receptors. Ann Surg 1995; 221(6): 767-777
22. Yano T, Ito K, Fukamachi H, Xin-Zi C, Hee-Jun W, Inoue K et al. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor β-induced apotosis. Mol Cell Biol 2006; 26(12): 4474-4488
23. Yasui W, Ito H, Yoshida K, Tahara E. Biological malignancy in human gastric carcinoma-molecular aspects [in Japanese]. Gan to Kagaku Ryoho 1991; 18(6): 927-933
24. Reed JA, McNutt NS, Preito VG, Albino AP. Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression. Am J Pathol 1994; 145(1): 97-104
25. Ito N, Kawata S, Tamura S, Shirai Y, Kiso S, Tsushima H et al. Positive correlation of plasma transforming growth factor-beta 1 levels with tumor vascularity in hepatocellular carcinoma. Cancer Lett 1995; 89(1): 45-48
26. Wikstrom P, Stattin P, Franck-Lissbrant I, Dember JE, Bergh A. Transforming growth factor beta1 is associated with angiogenesis, metastasis and poor clinical outcome in prostate cancer. Prostate 1998; 37(1): 19-29 (Pubitemid 28385181)
27. Friess H, Yamanaka Y, Buchler M et al. Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 1993; 105(6): 1846-1856 (Pubitemid 24002804)
28. Zheng MH, Fan Y, Wysocki S, Lau AT, Robertson T, Beilharz M et al. Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration. Am J Pathol 1994; 145(5): 1095-1104 (Pubitemid 24345657)
29. Jaquet K, Reinecke P, Schardt C, Friebe U, Nitsch T et al. Functional intactness of stimulatory and inhibitory autocrine loops in human renal carcinoma cell lines of the clear cell type. J Urol 1997; 157(6): 2345-2350 (Pubitemid 27208719)
30. Shim KS, Kim KH, Han WS, Park EB. Elevated serum levels of transforming growth factor-betal in patients with colorectal carcinoma. Cancer 0000; 85(3): 554-561
31. Kai T, Taketazu F, Kawakami M, Shimanuki K, Yamada S, Miyazono K et al. Distribution of transforming growth factor-β and its receptors in gastric carcinoma tissue. Jpn J Cancer Res 1996; 87(3): 296-304 (Pubitemid 26117061)
32. Maehara Y, Kakeji Y, Kabashima A, Emi Y, Watanabe A, Akazawa K et al. Role of transforming growth factor-betal in invasion and metastasis in gastric carcinoma. J Clin Oncol 1999; 17(2): 607-614 (Pubitemid 29075249)